Detalhe da pesquisa
1.
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
NPJ Breast Cancer
; 9(1): 1, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609389
2.
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
Clin Cancer Res
; 29(9): 1719-1729, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693175
3.
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.
NPJ Breast Cancer
; 8(1): 35, 2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314693